X0303 4 2010-06-01 0 0001047699 KING PHARMACEUTICALS INC KG 0001213334 MOYER CHARLES C/O KING PHARMACEUTICALS, INC. 501 FIFTH STREET BRISTOL TN 37620 1 0 0 0 Common Stock 2010-06-01 4 S 0 7000 8.57 D 32213 D This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2010. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.52 to $8.611, inclusive. The reporting person has provided to King Pharmaceuticals, Inc., and will provide upon request to any security holder of King Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ R. Charles Moyer 2010-06-03